Protalix BioTherapeutics, Inc. (PLX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $76.05M2011: $77.88M2012: $82.08M2013: $140.28M2014: $133.96M2015: $86.38M2016: $92.20M2017: $101.67M2018: $114.01M2019: $115.71M2020: $94.97M2021: $79.70M2022: $66.43M2023: $50.87M2024: $30.21M2025: $34.12M$34.12M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$34.12M+12.9%
2024$30.21M-40.6%
2023$50.87M-23.4%
2022$66.43M-16.7%
2021$79.70M-16.1%
2020$94.97M-17.9%
2019$115.71M+1.5%
2018$114.01M+12.1%
2017$101.67M+10.3%
2016$92.20M+6.7%
2015$86.38M-35.5%
2014$133.96M-4.5%
2013$140.28M+70.9%
2012$82.08M+5.4%
2011$77.88M+2.4%
2010$76.05M